Michele Montrone

5PUBLICATIONS
44CO-AUTHORS
Liquid biopsiesCancer diagnosisPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).

|May 27, 2026
Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices.

|Sep 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.

Alessio Cortellini, Valentina Santo, Leonardo Brunetti

|Mar 28, 2024
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.

Vito Longo, Annamaria Catino, Michele Montrone

|Mar 11, 2023
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review.

Michele Montrone, Gerardo Rosati, Vito Longo

Pageof 1

Frequent Collaborators

2 joint publications

Domenico Galetta

2 joint publications

Diego Luigi Cortinovis

2 joint publications

Emilio Bria

1 joint publications

Gerardo Rosati